CTIS.eu › Cities › Sweden › Orebro
Orebro
Sweden
129 total trials
60 recruiting
2023-506548-18-00
10
2022-11-10
Dermatitis atopic
2022-500966-82-00
5
2020-03-11
Resectable locally advanced squamous cell carcinoma (SCC) of the esoph
2025-524022-18-00
4
2026-05-22
Multiple myeloma
2025-522240-40-00
5
2026-03-05
Breast Cancer
2024-516966-12-00
4
2026-02-13
Alzheimer’s disease
2025-521686-27-01
4
2026-01-08
Major Depression
2025-521382-27-00
10
2025-12-04
Moderately to Severely Active Crohn's Disease
2025-521381-10-00
5
2025-12-03
Moderately to Severely Active Ulcerative Colitis
2023-503447-33-00
4
2025-11-13
febrile Urinary Tract Infection (fUTI)
2024-519871-24-00
10
2025-11-11
Breast cancer
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
2023-506135-14-00
11
2025-09-10
Breast cancer
2024-517247-31-00
5
2025-07-07
Newly Diagnosed Higher Risk Myelodysplastic Syndrome
2023-510294-34-00
5
2025-06-12
small lymphocytic lymphoma (SLL)
2024-513719-28-00
11
2025-06-04
Atrial fibrillation
2024-517457-27-00
5
2025-06-04
Chronic Obstructive Pulmonary Disease (COPD)
2024-514416-28-00
6
2025-04-09
Left ventricular thrombosis.
2023-506998-35-00
5
2025-01-08
Glioblastoma
2023-508398-10-00
6
2024-12-12
ANCA-associated vasculitis
2024-518857-41-00
6
2024-11-29
HPV infection and related diseases, such as cervical intraepithelial n
2023-505232-36-00
5
2024-11-15
Essential thrombocythemia
2023-509994-22-00
5
2024-11-15
cutaneous malignant melanoma
2023-510415-19-00
4
2024-08-28
Acute Myeloid Leukemia
2024-512438-14-00
6
2024-07-22
Pain during eye examination of premature infants.
Showing 25–48 of 129 trials